Hepatitis C in Adults Who Underwent Congenital Heart Surgery Before Screening
NCT00359099 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2013-11-27
Summary
This is a retrospective chart review. We hypothesize that patients who have undergone congenital heart surgery, prior to screening of blood products have a significant risk of hepatitis C infection and all such patients would benefit from screening for hepatitis C.
Conditions
- Congenital Heart Disease
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
William T Mahle, MD · Emory University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1980-01-31
- Completion
- 2006-07-31
Countries
- United States
Study Locations
More Related Trials
-
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
NCT01644903 ·Status: RECRUITING
-
Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.
NCT00213707 ·Status: UNKNOWN
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
NCT00867243 ·Status: TERMINATED
-
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
NCT01517529 ·Status: COMPLETED
-
Bartonella in Liver Transplant Patients
NCT02595710 ·Status: COMPLETED
-
Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C
NCT01428700 ·Status: COMPLETED
-
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy
NCT02877199 ·Status: COMPLETED
-
Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency
NCT06659588 ·Status: RECRUITING
-
Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy
NCT03226717 ·Status: UNKNOWN
-
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation
NCT00701272 ·Status: UNKNOWN
-
Prevalence of Hepatitis c Virus Infection Among Rheumatological Patients
NCT03587714 ·Status: COMPLETED
-
Autoantibodies and Direct-acting Antivirals
NCT03566966 ·Status: COMPLETED
-
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531 ·Status: WITHDRAWN
-
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
NCT05669677 ·Status: COMPLETED
-
Pathology of Hepatitis c Nephropathy
NCT03476031 ·Status: UNKNOWN
-
Assessment of the Different Etiological and Susceptibility Markers in Patients With Pancreatitis: Investigating IG4, Cytomegalovirus, Coxsackie- Virus, Genetic Polymorphism of Vitamin D Receptor Gene
NCT03830073 ·Status: UNKNOWN
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED
-
Bilirubin Levels to Diagnose Appendicitis and Predict Appendiceal Perforation
NCT06956638 ·Status: COMPLETED
-
Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic Patients
NCT03965260 ·Status: COMPLETED
-
Examining the Immune Response in Patients With Gaucher Disease and Hepatitis C
NCT01274208 ·Status: UNKNOWN
-
Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis
NCT03740685 ·Status: UNKNOWN
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
NCT06691529 ·Status: NOT_YET_RECRUITING
-
Hepatitis C Virus in Neutrophil Granulocyte Progenitor Cells
NCT02545387 ·Status: WITHDRAWN